Corporate Profile for Iomai Corporation, dated September 29, 2000

Business Wire, Sept 29, 2000

Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.

Published Date:   September 29, 2000

Company Name:     Iomai Corporation

Address:          2421 Pennsylvania Avenue, N.W.
                  Washington, DC 20037

Main Telephone
 Number:          202/955-7120

Internet Home
 Page Address
  (URL)           www.iomai.com

Chief Executive
 Officer:         Stanley C. Erck

Chief Financial
 Officer:         Jeff Daniel - accountant

Investor Relations
 Contact:         Russell P. Wilson
 Business number: 202/955-7120
 E-mail address:  ofcasst@iomai.com

Industry:         Biotech

Company description: Iomai is a biopharmaceutical company that is developing products using its proprietary Transcutaneous Immuno Modulation (TIM) technology to greatly enhance human immune systems in the fight against disease.

TIM works through the skin as a non-invasive booster to the body's own immune system and can be targeted against specific diseases. TIM products are administered easily and safely - stimulating the immune system to prevent or treat disease through a skin patch, without needles or injections.

Iomai is focused on rapid commercialization of the TIM technology through strategic relationships with industry partners. The TIM project pipeline includes products for three target markets: infectious diseases, cancer therapies and autoimmune therapies, all delivered through the skin, without needles.